These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28923177)
1. Androgens and cardiovascular disease in women and men. Armeni E; Lambrinoudaki I Maturitas; 2017 Oct; 104():54-72. PubMed ID: 28923177 [TBL] [Abstract][Full Text] [Related]
2. The effect of androgens on lipids. Monroe AK; Dobs AS Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242 [TBL] [Abstract][Full Text] [Related]
3. Serum androgen concentrations and subclinical measures of cardiovascular disease in men and women. Kische H; Gross S; Wallaschofski H; Völzke H; Dörr M; Nauck M; Felix SB; Haring R Atherosclerosis; 2016 Apr; 247():193-200. PubMed ID: 26926599 [TBL] [Abstract][Full Text] [Related]
4. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538 [TBL] [Abstract][Full Text] [Related]
5. Testosterone treatment in the aging male: myth or reality? Nigro N; Christ-Crain M Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease and androgens: a review. Kaushik M; Sontineni SP; Hunter C Int J Cardiol; 2010 Jun; 142(1):8-14. PubMed ID: 19923015 [TBL] [Abstract][Full Text] [Related]
7. Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men. Yeap BB Asian J Androl; 2018; 20(2):109-114. PubMed ID: 29199649 [TBL] [Abstract][Full Text] [Related]
8. Safety of estrogen/androgen regimens. Simon JA J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876 [TBL] [Abstract][Full Text] [Related]
9. Effects of androgens on the cardiovascular system. Rosano GM; Cornoldi A; Fini M J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358 [TBL] [Abstract][Full Text] [Related]
13. Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review. Crandall CJ; Barrett-Connor E Endocrinol Metab Clin North Am; 2013 Jun; 42(2):227-53. PubMed ID: 23702399 [TBL] [Abstract][Full Text] [Related]
14. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Undén AL; Elofsson S; Brismar K Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068 [TBL] [Abstract][Full Text] [Related]
15. Endogenous sex hormones and cardiovascular disease in men. Muller M; van der Schouw YT; Thijssen JH; Grobbee DE J Clin Endocrinol Metab; 2003 Nov; 88(11):5076-86. PubMed ID: 14602729 [TBL] [Abstract][Full Text] [Related]
16. Androgens and cardiovascular disease. Liu PY; Death AK; Handelsman DJ Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802 [TBL] [Abstract][Full Text] [Related]
19. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study. Khatibi A; Agardh CD; Shakir YA; Nerbrand C; Nyberg P; Lidfeldt J; Samsioe G Climacteric; 2007 Oct; 10(5):386-92. PubMed ID: 17852141 [TBL] [Abstract][Full Text] [Related]